Literature DB >> 9202235

An antisense oligodeoxynucleotide to lipocortin 1 reverses the inhibitory actions of dexamethasone on the release of adrenocorticotropin from rat pituitary tissue in vitro.

A D Taylor1, H C Christian, J F Morris, R J Flower, J C Buckingham.   

Abstract

Our previous studies have demonstrated that lipocortin 1 (LC1, also called annexin 1) is an important mediator of glucocorticoid action in the neuroendocrine system, particularly with regard to the powerful inhibitory actions of the steroids on the secretion of ACTH and its hypothalamic releasing hormones. In the present study, we have used an antisense oligodeoxynucleotide (ODN) unique to LC1 to investigate further the role of this protein in the regulatory effects of dexamethasone on ACTH release in vitro from rat anterior pituitary cells. Pituitary cells dispersed with collagenase retained their functional and morphological integrity in vitro and sequestered ODNs in a time-dependent manner from the incubation medium. LC1 was readily detected in the cells by Western blot analysis or by immunoprecipitation/autoradiography after preloading with 35S-methionine/cysteine; the bulk of the protein was contained within an intracellular pool but a small amount was attached to the outer cell surface (pericellular). Dexamethasone (100 nm, 2.5 h) initiated de novo synthesis of LC1; it also increased the amount of LC1 in the pericellular pool detected by either method and caused a concomitant decrease in intracellular LC1. The responses to the steroid were prevented by the inclusion in the medium of an LC1 antisense ODN (50 nM, 3.5 h) but the corresponding sense and scrambled ODN sequences were inert. None of the ODN sequences tested influence the expression of annexin 5 in the pituitary tissue. CRH-41 (100 pM-1 mM), forskolin (1 nM-1 mM) and an L-Ca2+-channel opener BAY K8644 (100 pM-1 microM) initiated concentration dependent increases in immunoreactive- (ir-) ACTH release from the pituitary cells that were reduced (P < 0.01) by preincubation with dexamethasone (100 nM, 2.5 h). The inhibitory effects of the steroid were reversed by the LC1 antisense ODN (50 nM, P < 0.01), whereas the LC1 sense and scrambled control sequences (50 nM) were both ineffective in this respect (P > 0.05). The results add further support to the view that the acute inhibitory effects of glucocorticoids on the secretion of ACTH by the pituitary gland are dependent on the generation of lipocortin 1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202235     DOI: 10.1210/endo.138.7.5260

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Evidence from immunoneutralization and antisense studies that the inhibitory actions of glucocorticoids on growth hormone release in vitro require annexin 1 (lipocortin 1).

Authors:  A D Taylor; H C Christian; J F Morris; R J Flower; J C Buckingham
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface.

Authors:  E Solito; H C Christian; M Festa; A Mulla; T Tierney; R J Flower; J C Buckingham
Journal:  FASEB J       Date:  2006-05-23       Impact factor: 5.191

3.  Multiple signaling pathways involved in stimulation of osteoblast differentiation by N-methyl-D-aspartate receptors activation in vitro.

Authors:  Jie-li Li; Lin Zhao; Bin Cui; Lian-fu Deng; Guang Ning; Jian-min Liu
Journal:  Acta Pharmacol Sin       Date:  2011-06-20       Impact factor: 6.150

Review 4.  Annexin 1, glucocorticoids, and the neuroendocrine-immune interface.

Authors:  Julia C Buckingham; Christopher D John; Egle Solito; Tanya Tierney; Roderick J Flower; Helen Christian; John Morris
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

5.  Lack of annexin 1 results in an increase in corticotroph number in male but not female mice.

Authors:  J F Morris; S Omer; E Davies; E Wang; C John; T Afzal; S Wain; J C Buckingham; R J Flower; H C Christian
Journal:  J Neuroendocrinol       Date:  2006-11       Impact factor: 3.627

6.  Rapid Glucocorticoid Feedback Inhibition of ACTH Secretion Involves Ligand-Dependent Membrane Association of Glucocorticoid Receptors.

Authors:  Qiong Deng; Denise Riquelme; Loc Trinh; Malcolm J Low; Melanija Tomić; Stanko Stojilkovic; Greti Aguilera
Journal:  Endocrinology       Date:  2015-06-29       Impact factor: 4.736

7.  Annexin 1 (lipocortin 1) mimics inhibitory effects of glucocorticoids on testosterone secretion and enhances effects of interleukin-1beta.

Authors:  Patricia O Cover; Frederick Baanah-Jones; Christopher D John; Julia C Buckingham
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

8.  Opposing influences of glucocorticoids and interleukin-1beta on the secretion of growth hormone and ACTH in the rat in vivo: role of hypothalamic annexin 1.

Authors:  J G Philip; C D John; P O Cover; J F Morris; H C Christian; R J Flower; J C Buckingham
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1.

Authors:  Samia Yazid; Egle Solito; Helen Christian; Simon McArthur; Nicolas Goulding; Roderick Flower
Journal:  Biochem Pharmacol       Date:  2009-03-24       Impact factor: 5.858

10.  The influence of 17beta-estradiol on annexin 1 expression in the anterior pituitary of the female rat and in a folliculo-stellate cell line.

Authors:  Evelyn Davies; Selma Omer; John F Morris; Helen C Christian
Journal:  J Endocrinol       Date:  2007-02       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.